| A placebo-controlled trial of prucalopride for severe chronic constipation M Camilleri, R Kerstens, A Rykx, L Vandeplassche New England Journal of Medicine 358 (22), 2344-2354, 2008 | 703 | 2008 |
| Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation–a 12‐week, randomized, double‐blind, placebo … EMM Quigley, L Vandeplassche, R Kerstens, J Ausma Alimentary pharmacology & therapeutics 29 (3), 315-328, 2009 | 440 | 2009 |
| Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives J Tack, M Van Outryve, G Beyens, R Kerstens, L Vandeplassche Gut 58 (3), 357-365, 2009 | 434 | 2009 |
| Early bactericidal activity and pharmacokinetics of the diarylquinoline TMC207 in treatment of pulmonary tuberculosis R Rustomjee, AH Diacon, J Allen, A Venter, C Reddy, RF Patientia, ... Antimicrobial agents and chemotherapy 52 (8), 2831-2835, 2008 | 377 | 2008 |
| Whole slide imaging versus microscopy for primary diagnosis in surgical pathology: a multicenter blinded randomized noninferiority study of 1992 cases (pivotal study) S Mukhopadhyay, MD Feldman, E Abels, R Ashfaq, S Beltaifa, ... The American journal of surgical pathology 42 (1), 39-52, 2018 | 373 | 2018 |
| Safety assessment of prucalopride in elderly patients with constipation: a double‐blind, placebo‐controlled study M Camilleri, G Beyens, R Kerstens, P Robinson, L Vandeplassche Neurogastroenterology & Motility 21 (12), 1256-e117, 2009 | 184 | 2009 |
| A double‐blind, placebo‐controlled study of prucalopride in elderly patients with chronic constipation S Müller‐Lissner, A Rykx, R Kerstens, L Vandeplassche Neurogastroenterology & Motility 22 (9), 991-e255, 2010 | 182 | 2010 |
| Efficacy and safety of prucalopride in patients with chronic noncancer pain suffering from opioid-induced constipation CEJ Sloots, A Rykx, M Cools, R Kerstens, M De Pauw Digestive diseases and sciences 55, 2912-2921, 2010 | 162 | 2010 |
| Prucalopride is effective in patients with severe chronic constipation in whom laxatives fail to provide adequate relief: results of a double-blind, placebo-controlled clinical … G Coremans, R Kerstens, M De Pauw, M Stevens Digestion 67 (1-2), 82-89, 2003 | 155 | 2003 |
| Clinical trial: the efficacy of open‐label prucalopride treatment in patients with chronic constipation–follow‐up of patients from the pivotal studies M Camilleri, MJ Van Outryve, G Beyens, R Kerstens, P Robinson, ... Alimentary pharmacology & therapeutics 32 (9), 1113-1123, 2010 | 148 | 2010 |
| A multicenter phase 2 study of the farnesyltransferase inhibitor tipifarnib in intermediate-to high-risk myelodysplastic syndrome P Fenaux, A Raza, GJ Mufti, C Aul, U Germing, H Kantarjian, L Cripe, ... Blood 109 (10), 4158-4163, 2007 | 137 | 2007 |
| A randomized, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy, safety, and tolerability of prucalopride in men with chronic constipation Y Yiannakou, H Piessevaux, M Bouchoucha, I Schiefke, R Filip, ... Official journal of the American College of Gastroenterology| ACG 110 (5 …, 2015 | 117 | 2015 |
| Effects of prucalopride on colonic transit, anorectal function and bowel habits in patients with chronic constipation CEJ Sloots, AC Poen, R Kerstens, M Stevens, M De Pauw, JC Van Oene, ... Alimentary pharmacology & therapeutics 16 (4), 759-767, 2002 | 113 | 2002 |
| Randomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo‐obstruction–a double‐blind, placebo‐controlled, cross‐over, multiple n= 1 study AV Emmanuel, MA Kamm, AJ Roy, R Kerstens, L Vandeplassche Alimentary pharmacology & therapeutics 35 (1), 48-55, 2012 | 104 | 2012 |
| Efficacy and safety of prucalopride in chronic constipation: an integrated analysis of six randomized, controlled clinical trials M Camilleri, H Piessevaux, Y Yiannakou, J Tack, R Kerstens, ... Digestive diseases and sciences 61, 2357-2372, 2016 | 95 | 2016 |
| Prucalopride is no more effective than placebo for children with functional constipation SM Mugie, B Korczowski, P Bodi, A Green, R Kerstens, J Ausma, M Ruth, ... Gastroenterology 147 (6), 1285-1295. e1, 2014 | 93 | 2014 |
| Gender differences in local and systemic reactions to inactivated influenza vaccine, established by a meta-analysis of fourteen independent studies WEP Beyer, AM Palache, R Kerstens, N Masurel European Journal of Clinical Microbiology and Infectious Diseases 15, 65-70, 1996 | 93 | 1996 |
| Prucalopride improves bowel function and colonic transit time in patients with chronic constipation: an integrated analysis A Emmanuel, M Cools, L Vandeplassche, R Kerstens Official journal of the American College of Gastroenterology| ACG 109 (6 …, 2014 | 90 | 2014 |
| Effect of prucalopride on symptoms of chronic constipation J Tack, V Stanghellini, D Dubois, A Joseph, L Vandeplassche, R Kerstens Neurogastroenterology & Motility 26 (1), 21-27, 2014 | 89 | 2014 |
| Efficacy and tolerability of prucalopride in patients with constipation due to spinal cord injury K Krogh, MB Jensen, P Gandrup, S Laurberg, J Nilsson, R Kerstens, ... Scandinavian journal of gastroenterology 37 (4), 431-436, 2002 | 84 | 2002 |
